Hidradenitis Suppurativa Medications

ADALIMUMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

Humira (adalimumab) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease and ulcerative colitis. Humira is also available as a biosimilar. Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Humira may be covered by your Medicare or insurance plan.

ADALIMUMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

ADALIMUMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

Yuflyma (adalimumab-aaty) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease and ulcerative colitis. Yuflyma is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Yuflyma may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Hadlima (adalimumab-bwwd) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, hidradenitis suppurativa, uveitis and ulcerative colitis. Hadlima is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Hadlima may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

ADALIMUMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

Amjeveta (adalimumab-atto) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Amjeveta is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Amjeveta may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Yusimry (adalimumab-aqvh) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, hidradenitis suppurativa, uveitis and ulcerative colitis. Yusimry is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Yusimry may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Hyrimoz (adalimumab-adaz) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Hyrimoz is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Hyrimoz may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Abrilada (adalimumab-afzb) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, hidradenitis suppurativa, uveitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Abrilada is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Abrilada is a TNF blocker which works by reducing inflammation throughout the body. The most common form of Abrilada is a carton of two 40mg/0.8mg syringes. It is also available as a vial. It is covered by some Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower.

Adalimumab-ryvk (Simlandi) is part of the TNF Blockers class and treats Plaque Psoriasis, Juvenile Idiopathic Arthritis, Uveitis and other conditions. TNF blockers are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis and ulcerative colitis. They work by reducing inflammation throughout the body, including in the joints, skin, eyes, and intestines. Adalimumab-ryvk (Simlandi) is only available as a brand name drug.

Hulio (adalimumab-fkjp) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, hidradenitis suppurativa, uveitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Hulio is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Hulio may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

SECUKINUMAB treats autoimmune conditions, such as psoriasis and arthritis. It works by slowing down an overactive immune system. It is a monoclonal antibody.

Cyltezo (adalimumab-adbm) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, hidradenitis suppurativa, uveitis and ulcerative colitis. Cyltezo is an interchangeable biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Cyltezo may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.